Congressman Demands DOJ Update on Marijuana Rescheduling
The marijuana rescheduling update remains pending as the DOJ has yet to respond three months after the executive order. This delay impacts federal cannabis policy and clinical practice by limiting research and insurance coverage. Clinicians face ongoing…
Hemp Groups Plan Legal Challenge Against Industry-Destroying Regulations
Hemp groups legal challenge is mounting against new state regulations that threaten patient access to hemp-derived products. These changes could disrupt the availability of CBD and other therapeutic hemp products. Patients and clinicians face challenges…
Second Time’s a Charm for Omnibus Cannabis Bill
The omnibus cannabis bill session daily highlights significant legislative reform affecting medical cannabis access and regulation. This bill impacts patient access, provider guidelines, and regulatory frameworks. Clinicians and patients should monitor…
Auxly Reports Fourth Quarter and Full Year 2025 Results
Cannabis companies ended 2025 with weakening financial positions, affecting supply chain reliability and patient access to medical cannabis products. Auxly's financial results reflect broader market conditions impacting licensed producers. Monitoring…
White House Schedules Meeting On Cannabis Products Enforcement Policy For Next Week
The White House has scheduled a meeting on cannabis products enforcement policy, signaling potential federal regulatory changes. This policy directly affects patient access to cannabis medications and clinical practice. Healthcare providers should…
San Antonio shops prepare for financial impacts of smokeable hemp ban | kens5.com
Local hemp bans are causing financial impacts for San Antonio shops due to the smokeable hemp ban. These bans affect patient access to federally legal hemp products. Clinicians must navigate these local hemp bans when advising patients.
White House Schedules Meeting on FDA’s New CBD Compliance Enforcement Policy
The latest cbd industry news highlights the White House scheduling a meeting on FDA's new compliance enforcement policy. This policy affects product quality standards and patient access to CBD. Clinicians and patients should monitor these regulatory…
Understanding 2026 Hemp Total THC Regulation and Patient Access
The 2026 hemp total THC regulation may redefine legal hemp products by including THCA and other precursors in total THC calculations. This change could affect patient access to currently legal hemp-derived cannabinoids. Clinicians should monitor these…
Cannabis retailer Zen Leaf approved for extension on move to new Meriden location
Dispensary relocations patient access is critical for consistent cannabis medicine delivery. Zen Leaf's approved extension in Meriden highlights regulatory efforts to maintain patient access. Patients should plan ahead to avoid disruptions during…
Marijuana Leaf and Vapes Now Accessible to Medical Cannabis Patients
Vapes available for medical cannabis patients provide rapid onset and precise dosing, enhancing therapeutic outcomes. This new bill expands access to vaporized cannabis, a preferred delivery method with distinct pharmacokinetics. Clinicians now have more…
